3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase NA
1
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
73
Carcinoma, Hepatocellular
67
Stomach Neoplasms
52
Pancreatic Neoplasms
40
Rectal Neoplasms
30
Colonic Neoplasms
30
Neoplasms
21
Liver Neoplasms
20
Esophageal Neoplasms
19
Neoplasm Metastasis
16
Cholangiocarcinoma
16
Esophageal Squamous Cell Carcinoma
14
Gallbladder Neoplasms
12
Biliary Tract Neoplasms
12
Lung Neoplasms
10
Gastrointestinal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Ovarian Neoplasms
6
Prostatic Neoplasms
5
Neoplasms by Site
5
Bile Duct Neoplasms
5
Adenocarcinoma
5
Polyps
4
Neoplasms by Histologic Type
4
Melanoma
4
Hematologic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Adenoma
4
Recurrence
3
Interventions
Ursodeoxycholic Acid
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Genetic Diseases, Inborn
×
Gastrointestinal
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled